Trevi Therapeutics to Participate in Upcoming May Investor Events
/PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral...
Source: prnewswire.com